Clinical Trials Directory

Trials / Completed

CompletedNCT02406274

Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
249 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
Female
Age
25 Years
Healthy volunteers
Not accepted

Summary

Contrast Enhanced Spectral Mammography (CESM) is an advanced form of mammography which is performed after injection of contrast or dye into a vein in the arm. This dye is the same dye that is used for CT scans. This type of mammogram includes a regular mammogram as well as additional pictures with the dye. This particular study is being done to determine if by adding the dye in the veins the investigators are better able to identify the cause of the lump than if they just did the regular mammogram alone.

Conditions

Interventions

TypeNameDescription
OTHERContrast Enhanced Spectral Mammography (CESM)Women presenting to MSKCC with a palpable abnormality within the breast either self palpated \& or palpated by their physician will be offered CESM instead of FFDM alone. The breast imager assigned to care for the patient will interpret the low energy images (including any additional views they routinely obtain) \& record their findings. They will then interpret the CESM \& record those results. As per standard of care, the patient will have a targeted ultrasound as well. Appropriate clinical recommendations will be made. In patients with no specific imaging findings, follow-up will be determined by the degree of suspicion of the palpable finding \& will either be called negative \& followed clinically if not suspicious, or will go on to MRI , percutaneous biopsy by a surgeon or surgical biopsy if suspicious.

Timeline

Start date
2015-03-01
Primary completion
2024-06-27
Completion
2024-06-27
First posted
2015-04-02
Last updated
2024-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02406274. Inclusion in this directory is not an endorsement.